Trial intelligence / Profile preview

UNLOCK: Anesthetic Monitoring System

NCT03928366Phase 2Completed

Sponsor
Parc de Salut Mar
Start
Jun 2017
Primary completion
Jan 2019
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of propofol, remifentanil, sponsored by Parc de Salut Mar. Started Jun 2017; status: completed.

02

Drugs

propofolremifentanil

Beyond the preview

Go deeper on NCT03928366.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03928366.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call